To the full analysis
Buyback calculator for National HealthCare
National HealthCare stock: key metrics
NHCNational HealthCare had an operating margin of 8.5% and a return on invested capital (ROIC) of 10.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 72.0% | 8.5% | 6.5% |
| 2007 | 16.0% | 6.5% | 7.6% |
| 2008 | 15.0% | 5.9% | 5.7% |
| 2009 | 16.4% | 7.6% | 6.0% |
| 2010 | 44.5% | 8.0% | 7.3% |
| 2011 | 44.6% | 10.2% | 8.4% |
| 2012 | 43.9% | 9.0% | 7.8% |
| 2013 | 42.5% | 9.1% | 8.2% |
| 2014 | 41.5% | 7.8% | 6.1% |
| 2015 | 41.2% | 7.4% | 5.9% |
| 2016 | 40.7% | 6.6% | 5.5% |
| 2017 | 40.7% | 5.6% | 5.8% |
| 2018 | 40.6% | 5.7% | 6.0% |
| 2019 | 40.5% | 4.9% | 6.8% |
| 2020 | 37.9% | 4.9% | 4.3% |
| 2021 | 34.1% | 5.0% | 13.7% |
| 2022 | 36.1% | 3.0% | 2.1% |
| 2023 | 37.6% | 5.0% | 5.9% |
| 2024 | 37.5% | 6.6% | 7.9% |
| 2025 | 39.3% | 8.5% | 7.9% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 14.7% | 23.4% | 7.8% |
| 2007 | 10.0% | 9.4% | 6.5% |
| 2008 | 7.6% | 6.4% | 4.7% |
| 2009 | 7.6% | 7.2% | 5.1% |
| 2010 | 9.4% | 9.5% | 6.4% |
| 2011 | 10.6% | 13.2% | 7.5% |
| 2012 | 9.0% | 9.5% | 6.4% |
| 2013 | 9.4% | 8.8% | 6.6% |
| 2014 | 7.3% | 7.8% | 5.0% |
| 2015 | 8.4% | 6.9% | 5.1% |
| 2016 | 7.5% | 6.1% | 4.6% |
| 2017 | 8.0% | 6.5% | 5.1% |
| 2018 | 8.0% | 7.0% | 5.5% |
| 2019 | 8.8% | 5.3% | 5.3% |
| 2020 | 5.3% | 5.2% | 3.1% |
| 2021 | 15.3% | 6.3% | 9.9% |
| 2022 | 2.6% | 2.9% | 1.8% |
| 2023 | 7.4% | 5.3% | 5.1% |
| 2024 | 10.4% | 7.3% | 6.7% |
| 2025 | 11.2% | 10.6% | 7.9% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026, previously Strong
- Valuation signal Fairly valued since 7 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.